Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Vitamin D Supplementation in Lean PCOS Patients (Leanvit-D)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03898934
Recruitment Status : Recruiting
First Posted : April 2, 2019
Last Update Posted : April 8, 2019
Sponsor:
Information provided by (Responsible Party):
Ayman S Dawood, MD, Tanta University

Brief Summary:
To assess whether Vitamin D supplementations for lean patients with polycystic ovary syndrome in conjunction with clomiphene citrate are beneficial or not

Condition or disease Intervention/treatment Phase
PCOS Drug: Vitamin D Drug: Placebo Oral Tablet Phase 4

Detailed Description:
This study is double blinded randomized controlled study conducted at Tanta University hospitals in the period from September 2017 to December 2018. Patients and methods: One hundred twelve patients were recruited and randomly allocated into 2 groups; study group with Vitamin D supplementation and control group without Vitamin D supplementation.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 60 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: The 2 groups will be treated at the same time
Masking: Double (Participant, Care Provider)
Masking Description: Both patients and gynecologists were binded
Primary Purpose: Treatment
Official Title: Dose Vitamin D Supplementation in Lean Patients With Polycystic Ovary Syndrome Improves Ovulation and Pregnancy Rates
Actual Study Start Date : April 1, 2019
Estimated Primary Completion Date : December 31, 2019
Estimated Study Completion Date : December 31, 2019

Resource links provided by the National Library of Medicine

Drug Information available for: Vitamin D

Arm Intervention/treatment
Experimental: Vitamin D group
These patients will receive 6000IU daily for 8 weeks then 2000IU maintenance till pregnancy or end of study
Drug: Vitamin D
receive 6000iu daily for 8 weeks

Placebo Comparator: Placebo group
These group will receive placebo for the same periods of study group
Drug: Placebo Oral Tablet
placebo for the same period




Primary Outcome Measures :
  1. Ovulation rate [ Time Frame: 3 months ]
    Number of mature follicles obtained

  2. Pregnancy rate [ Time Frame: 3 months ]
    Number of patients who get pregnant



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   20 Years to 35 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Lean
  • PCOS
  • Infertile
  • Vitamin D deficient

Exclusion Criteria:

  • Age less than 20 and more than 35
  • Non PCOS patients
  • Obese patients
  • Previous ovarian surgery
  • Previous oophrectomy of one ovary

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03898934


Contacts
Layout table for location contacts
Contact: Ayman Dawood, MD +201020972067 ayman.dawood@med.tanta.edu.eg
Contact: Adel Elgergawy, MD +201002057250 dradelali775@gmail.com

Locations
Layout table for location information
Egypt
Ayman Shehata Dawood Recruiting
Tanta, Algharbia, Egypt, 31111
Contact: Ahmed Elhalwagy, MD    +201020972067    halwagy22@yahoo.com   
Contact: Hesham Salem, MD    +20122348805    prof.hesham_salem@hotmail.com   
Ayman Shehata Dawood Recruiting
Tanta, Algharbia, Egypt, 31111
Contact: Salah Naglah, MD       salahnaglah@yahoo.com   
Contact: Adel Elgergawy, MD    01002057250 ext 002    dradelali775@gmail.com   
Sponsors and Collaborators
Tanta University

Layout table for additonal information
Responsible Party: Ayman S Dawood, MD, Lecturer, Tanta University
ClinicalTrials.gov Identifier: NCT03898934     History of Changes
Other Study ID Numbers: Lean Vitamin D
First Posted: April 2, 2019    Key Record Dates
Last Update Posted: April 8, 2019
Last Verified: April 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes
Plan Description: The investigators will share results
Supporting Materials: Study Protocol
Time Frame: 3 months

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Ayman S Dawood, MD, Tanta University:
Lean PCOS
Vitamin D
Supplementation
Ovulation
Pregnancy

Additional relevant MeSH terms:
Layout table for MeSH terms
Polycystic Ovary Syndrome
Ovarian Cysts
Cysts
Neoplasms
Ovarian Diseases
Adnexal Diseases
Genital Diseases, Female
Gonadal Disorders
Endocrine System Diseases
Vitamin D
Ergocalciferols
Vitamins
Micronutrients
Nutrients
Growth Substances
Physiological Effects of Drugs
Bone Density Conservation Agents
Calcium-Regulating Hormones and Agents